SAN DIEGO (AP) — SAN DIEGO (AP) — Capricor Therapeutics Inc. (CAPR) on Wednesday reported a loss of $7.1 million in its fourth quarter.
On a per-share basis, the San Diego-based company said it had a loss of 16 cents.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.
The biotechnology company posted revenue of $11.1 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $3.2 million.
For the year, the company reported that its loss widened to $40.5 million, or $1.15 per share. Revenue was reported as $22.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
